Literature DB >> 3553513

Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation.

S Feldman, A L Bisno, L Lott, R Dodge, R E Jackson.   

Abstract

The rate of streptococcal eradication after intramuscular administration of benzathine penicillin G in 66 children with acute group A streptococcal pharyngitis was determined and possible reasons for treatment failure explored. Bacteriologic treatment failure, defined as isolation of the same serotype at 3- or 6-weeks follow-up, occurred in eight (12%) patients. The treatment failure rate was 21% in those with immunologically significant infection, versus 8% in those without antibody rises (P greater than 0.1). All group A beta-hemolytic streptococcal (GABS) strains isolated from patients with treatment failure, both before and after benzathine penicillin G therapy, were exquisitely susceptible to penicillin G (minimum inhibitory concentration less than or equal to 0.02 microgram/mL), and none showed evidence of tolerance (minimum bactericidal concentration less than or equal to 0.04 microgram/mL). Thus, we found GABS eradication rates to exceed 10% in children given benzathine penicillin G. The failure rate did not appear to be related to enrichment of the patient population with a high proportion of asymptomatic carriers nor to the presence of penicillin-tolerant GABS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553513     DOI: 10.1016/s0022-3476(87)80024-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of Streptococcus pyogenes pharyngitis.

Authors:  F Fitoussi; R Cohen; G Brami; C Doit; N Brahimi; F de la Rocque; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

3.  Association of penicillin-tolerant streptococci with epidemics of streptococcal pharyngitis in closed communities.

Authors:  R Dagan; M Ferne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

4.  Penicillin tolerance of group A streptococci.

Authors:  C Betriu; E Campos; C Cabronero; A Fernandez; J J Picazo; A R Noriega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 5.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

6.  Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.

Authors:  K J Tack; D C Henry; W M Gooch; D N Brink; C H Keyserling
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

7.  Cefcanel daloxate versus penicillin in acute streptococcal pharyngotonsillitis.

Authors:  A Grunfeld; P Sinclair; L Nicolle
Journal:  Can J Infect Dis       Date:  1994-05

8.  Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic.

Authors:  L Nguyen; D Levy; A Ferroni; P Gehanno; P Berche
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

9.  Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing.

Authors:  J M Musser; B M Gray; P M Schlievert; M E Pichichero
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

10.  Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme.

Authors:  D Nelson; L Loomis; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.